Etofenamate is a non-steroidal anti-inflammatory drug and diethylene glycol ester form of flufenamic acid that has anti-inflammatory and analgesic activities.It inhibits lipoxygenase isolated from guinea pig leukocytes and the production of prostaglandin E2 in stimulated rat peritoneal macrophages.
This report contains market size and forecasts of Etofenamate in global, including the following market information:
Global Etofenamate Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Etofenamate Market Sales, 2017-2022, 2023-2028, (Kg)
Global top five Etofenamate companies in 2021 (%)
The global Etofenamate market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Min Purity Less Than 98% Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Etofenamate include Merck, Santa Cruz Biotechnology, Cayman Chemical, LGC, LifeSpan BioSciences, Biosynth Carbosynth, Selleck Chemicals, Shimadzu and KareBay Biochem, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Etofenamate manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Etofenamate Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Etofenamate Market Segment Percentages, by Type, 2021 (%)
Min Purity Less Than 98%
Min Purity 98%-99%
Min Purity More Than 99%
Global Etofenamate Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Etofenamate Market Segment Percentages, by Application, 2021 (%)
Research
Medical
Global Etofenamate Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Etofenamate Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Etofenamate revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Etofenamate revenues share in global market, 2021 (%)
Key companies Etofenamate sales in global market, 2017-2022 (Estimated), (Kg)
Key companies Etofenamate sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck
Santa Cruz Biotechnology
Cayman Chemical
LGC
LifeSpan BioSciences
Biosynth Carbosynth
Selleck Chemicals
Shimadzu
KareBay Biochem
BOC Sciences
Fluorochem
LKT Laboratories
BioCrick BioTech